DrugPatentWatch Database Preview» See Plans and Pricing
« Back to Dashboard
Cyproheptadine hydrochlorideis the generic ingredient in two branded drugs marketed by Actavis Mid Atlantic, Anda Repository, Elysium, Halsey, Lannett Co Inc, Lyne, Morton Grove, Naska, Pharm Assoc, Quagen, Merck, Am Therap, Apex Pharms Inc, Appco, Ascot, Beximco Pharms Usa, Boscogen, Chartwell Rx, Duramed Pharms Barr, Fosun Pharma, Heritage Pharma, Kv Pharm, Md Pharm, Mountain, Mylan, Novast Labs, Par Pharm, Pioneer Pharms, Pliva, Strides Pharma, Superpharm, Vitarine, Watson Labs, and Zydus Pharms, and is included in thirty-nine NDAs. Additional information is available in the individual branded drug profile pages.
There are six drug master file entries for cyproheptadine hydrochloride. Twenty-four suppliers are listed for this compound.
Summary for cyproheptadine hydrochloride
Recent Clinical Trials for cyproheptadine hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
|Kinnov Therapeutics||Phase 2|
|All India Institute of Medical Sciences, Bhubaneswar||Phase 4|